EcoDrugPlus

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSELUG00000000471
Gene Symbol: AVPR1A
3 Cross references
186 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSELUG00000010021
Gene Symbol: AVPR2
3 Cross references
210 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSELUG00000007172
Gene Symbol: AHR
3 Cross references
155 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1

Ensembl ID : ENSELUG00000008761
Gene Symbol: LOC105019161
2 Cross references
191 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1

Ensembl ID : ENSELUG00000001104
Gene Symbol: LOC105012681
3 Cross references
196 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSELUG00000019389
Gene Symbol: AURKA
3 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSELUG00000010719
Gene Symbol: LOC105007115
3 Cross references
205 Possible Orthologues:

Beta-2 Adrenergic Receptor

Ensembl ID : ENSELUG00000007046
Gene Symbol: LOC105026282
3 Cross references
196 Possible Orthologues:

Beta-2 Adrenergic Receptor

Ensembl ID : ENSELUG00000022105
Gene Symbol: LOC105011275
3 Cross references
150 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSELUG00000009044
Gene Symbol: BACE1
3 Cross references
221 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSELUG00000009052
Gene Symbol: BDKRB2
1 Cross references
160 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSELUG00000006425
Gene Symbol: BDKRB2
3 Cross references
151 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).